High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.8M
$9,754,741
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AXSM
S
Axsome Therapeutics, Inc.
Coleman Mark
• Director
10b5-1 SellΔOwn -34.6%
2026-02-26
$4,027,750Large
|
||||||
| AXSM |
Axsome Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -34.6%
|
2026-02-26 | $4,027,750Large | S | Form 4 |
| AXSM |
Axsome Therapeutics, Inc.
|
COO
Other
|
2026-02-26 | $100,827 | M | Form 4 |
| AXSM |
Axsome Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-02-26 | $5,726,991Whale | S | Form 4 |
| AXSM |
Axsome Therapeutics, Inc.
|
Director
Other
|
2026-02-23 | $30,938 | M | Form 4 |
| AXSM |
Axsome Therapeutics, Inc.
|
Director
Other
|
2026-02-20 | $61,801 | M | Form 4 |
| AXSM |
Axsome Therapeutics, Inc.
|
Director
Other
|
2026-02-10 | $41,648 | M | Form 4 |